Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis
- Conditions
- Adrenal Suppression
- Registration Number
- NCT01799408
- Lead Sponsor
- The Nazareth Hospital, Israel
- Brief Summary
To evaluate the effect of intra-articular corticosteroid injection (IACI) of depot preparation of betamethasone on the hypothalamic-pituitary-adrenal (HPA) axis, in patients with osteoarthritis of the knee
- Detailed Description
Consecutive patients attending the rheumatology or orthopedic clinic with osteoarthritic knee pain, not responding satisfactorily to medical or physical therapy were allocated to group-1 after consent and given IACI of 6 mg of betamethasone acetate/betamethasone sodium phosphate. Following completion of this part, consecutive age- and sex-matched patients were allocated to group-2 and given intra-articular injection of 60 mg of sodium hyaluronate. Just prior to the knee injection and 1, 2, 3, 4 and 8 weeks later, patients had 1 µg adrenocorticotropin hormone (ACTH) stimulation test. Secondary adrenal insufficiency (SAI) was defined as levels of less than 18 ng/ml or a rise of \< than 7 ng/ml of serum cortisol, 30 minutes following the ACTH stimulation test.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Osteoarthritis of the knee
- Had steroids in the last 3 months. Allergic to steroids
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adrenal Suppression 2 months Adrenal gland suupresion and inability to adequately secrete cortisol in response to stress
- Secondary Outcome Measures
Name Time Method favorable clinical response 2 months Favorable clinical response 2 months following the steroid injection Improvement of knee pain by more than 30 points according to visual analogue scale